Company Filing History:
3 out of 167 
3 out of 822 
Years Active: 2014-2018
Title: Huanqiu Li: Innovator in Pharmaceutical Modulation
Introduction
Huanqiu Li is a notable inventor based in Wilmette, IL, who has made significant contributions to the field of pharmaceutical sciences. He holds three patents that focus on innovative compounds and methods for treating various disease conditions. His work is characterized by a deep understanding of receptor modulation, particularly concerning 5-HT receptors.
Latest Patents
Li's latest patents include groundbreaking applications related to modulators of 5-HT receptors. These patents describe aryl- and heteroaryl-fused decahydropyrroloazepine, octahydrooxepinopyrrole, octahydropyrrolothiazepine dioxide, decahydrocyclohepta[c]pyrrole, and octahydrocyclohepta[c]pyrrole derivatives. The applications detail the compounds' formulas and their potential uses in treating various disease conditions. Additionally, they cover the processes for making these compounds and methods for identifying them.
Career Highlights
Throughout his career, Huanqiu Li has worked with prominent companies in the pharmaceutical industry, including AbbVie Deutschland GmbH & Co. KG and AbbVie Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in drug development and therapeutic applications.
Collaborations
Li has collaborated with esteemed colleagues such as Irini Akritopoulou-Zanze and Wilfried Martin Braje. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical solutions.
Conclusion
Huanqiu Li's contributions to the field of pharmaceutical modulation through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in treating disease conditions effectively.